Psychiatrists prescribing Wegovy?
August 04, 2023
Complicated by other factors such as inadequate access to healthy food and lower physical activity, over half of patients with bipolar depression and schizophrenia are overweight or obese. Novo Nordisk's Wegovy is self-injected once a week and has been shown to help patients lose around 15% of their body weight, making it the most effective treatment available."It's been a real welcome addition ….
Beyond severe mental health disorders, other patients struggling with obesity tend to suffer from mental health issues like depression and anxiety at higher levels than the general population, studies show. Clinical trials for Wegovy, which belongs to a class of drugs known as GLP-1 agonists that began as diabetes medicines, excluded psychiatric patients, a common practice in drug development.
The Danish drugmaker is"continuously performing surveillance of the data from ongoing clinical trials and real-world use of its products," said spokesperson Natalia Salomao in an email.Psychiatrists interviewed by Reuters said they are already vigilant about suicide risk in their patients, and have experience in closely monitoring for signs of distress whenever they add a new medication. Dr.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Bites and Stings: When to Prescribe an AntibioticStay up-to-date and safe this summer with the latest NICE antimicrobial prescribing guidelines for insect, animal, and human bites! Thanks to Dr. Caroline Ward for summarizing the recommendations. NICEguidelines
Weiterlesen »
Teens Are Being Left to Detox From Opioids Without MedicationMost areas of the U.S. lack facilities that offer medically managed withdrawal for patients under 18.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »